aspergillomarasmine a has been researched along with aspartic acid in 14 studies
Studies (aspergillomarasmine a) | Trials (aspergillomarasmine a) | Recent Studies (post-2010) (aspergillomarasmine a) | Studies (aspartic acid) | Trials (aspartic acid) | Recent Studies (post-2010) (aspartic acid) |
---|---|---|---|---|---|
17 | 0 | 15 | 23,005 | 417 | 4,018 |
Protein | Taxonomy | aspergillomarasmine a (IC50) | aspartic acid (IC50) |
---|---|---|---|
Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 1.638 | |
Excitatory amino acid transporter 1 | Homo sapiens (human) | 90.1265 | |
Excitatory amino acid transporter 2 | Homo sapiens (human) | 11 | |
Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 1.638 | |
Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 1.638 | |
Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 1.638 | |
Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 1.638 | |
Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 1.638 | |
Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 1.638 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (14.29) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 9 (64.29) | 24.3611 |
2020's | 3 (21.43) | 2.80 |
Authors | Studies |
---|---|
Friis, P; Møller, BL; Olsen, CE | 1 |
Arai, K; Asakura, R; Ashikawa, N; Ashizawa, N; Kobayashi, F; Matsuura, A; Okumura, H; Takahashi, M | 1 |
Courvalin, P; Meziane-Cherif, D | 1 |
Coombes, BK; De Pascale, G; King, AM; King, DT; Reid-Yu, SA; Strynadka, NC; Walsh, TR; Wang, W; Wright, GD | 1 |
Hong, B; Lei, X; Liao, D; Wang, J; Wu, F; Yang, S; Zhang, J | 1 |
Capretta, A; King, AM; Koteva, K; Wright, GD | 1 |
Al-Karmi, S; Albu, SA; Capretta, A; King, AM; Koteva, K; Wright, GD | 1 |
Dolgin, E | 1 |
Bai, Y; Guo, Q; Lei, X; Song, F; Wang, S; Wei, Q; Yang, S; Zhang, J; Zhang, L | 1 |
Adkins, Z; Aitha, M; Bergstrom, A; Bonomo, RA; Brodbelt, JS; Burnett, M; Cheng, Z; Crowder, MW; Fast, W; Hill, J; Katko, A; Martin, NI; Mehaffey, MR; Page, RC; Tehrani, KHME; Tierney, DL; Wright, GD; Yang, H | 1 |
Bai, Y; Guo, Q; Lei, X; Wang, S; Zhang, J; Zhou, J | 1 |
Brüchle, NC; Fu, H; Martin, NI; Mashayekhi, V; Poelarends, GJ; Prats Luján, A; Tehrani, KHME; van Haren, MJ | 1 |
Amatuni, A; Li, J; Renata, H | 1 |
Martin, NI; Rotondo, CM; Sychantha, D; Tehrani, KHME; Wright, GD | 1 |
1 review(s) available for aspergillomarasmine a and aspartic acid
Article | Year |
---|---|
Recent advances in the chemoenzymatic synthesis of bioactive natural products.
Topics: Aspartic Acid; Biocatalysis; Biological Products; Enzymes; Isoquinolines; Kainic Acid; Molecular Conformation; Podophyllotoxin; Quinolines; Quinolones; Stereoisomerism | 2020 |
13 other study(ies) available for aspergillomarasmine a and aspartic acid
Article | Year |
---|---|
Toxin production in Pyrenophora teres, the ascomycete causing the net-spot blotch disease of barley (Hordeum vulgare L.).
Topics: Ascomycota; Aspartic Acid; Hordeum; Molecular Structure; Mycotoxins; Plant Diseases | 1991 |
Pharmacological profiles of aspergillomarasmines as endothelin converting enzyme inhibitors.
Topics: Animals; Aorta; Aspartic Acid; Aspartic Acid Endopeptidases; Cattle; Edetic Acid; Endothelin-Converting Enzymes; Endothelins; Endothelium, Vascular; Glycopeptides; Hypertension; In Vitro Techniques; Lethal Dose 50; Male; Metalloendopeptidases; Mice; Mice, Inbred ICR; Rats; Rats, Sprague-Dawley | 1993 |
Antibiotic resistance: to the rescue of old drugs.
Topics: Animals; Aspartic Acid; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Female; Gram-Negative Bacteria; Meropenem; Thienamycins | 2014 |
Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance.
Topics: Animals; Anti-Bacterial Agents; Aspartic Acid; Aspergillus; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Biological Products; Carbapenems; Drug Evaluation, Preclinical; Drug Synergism; Female; Gram-Negative Bacteria; Klebsiella pneumoniae; Meropenem; Mice; Thienamycins | 2014 |
Total Synthesis and Structural Reassignment of Aspergillomarasmine A.
Topics: Aspartic Acid; Humans; Molecular Structure | 2016 |
Total Synthesis and Activity of the Metallo-β-lactamase Inhibitor Aspergillomarasmine A.
Topics: Aspartic Acid; Aspergillus; beta-Lactamase Inhibitors; beta-Lactamases; Dose-Response Relationship, Drug; Molecular Structure; Structure-Activity Relationship | 2016 |
Total Synthesis of Aspergillomarasmine A and Related Compounds: A Sulfamidate Approach Enables Exploration of Structure-Activity Relationships.
Topics: Acinetobacter; Amides; Anti-Bacterial Agents; Aspartic Acid; beta-Lactamases; Dose-Response Relationship, Drug; Enterobacteriaceae; Enzyme Inhibitors; Microbial Sensitivity Tests; Molecular Structure; Pseudomonas; Structure-Activity Relationship | 2016 |
Inner Workings: Combating antibiotic resistance from the ground up.
Topics: Anti-Bacterial Agents; Aspartic Acid; Aspergillus; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Mycotoxins; Soil Microbiology | 2016 |
Synthesis and biological evaluation of Aspergillomarasmine A derivatives as novel NDM-1 inhibitor to overcome antibiotics resistance.
Topics: Aspartic Acid; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2017 |
Probing the Interaction of Aspergillomarasmine A with Metallo-β-lactamases NDM-1, VIM-2, and IMP-7.
Topics: Aspartic Acid; beta-Lactamase Inhibitors; beta-Lactamases; Biological Products; Cobalt; Enzyme Activation; Kinetics; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Structure; Protein Binding; Quantitative Structure-Activity Relationship; Zinc | 2018 |
Total Syntheses of Natural Metallophores Staphylopine and Aspergillomarasmine A.
Topics: Aspartic Acid; Imidazoles; Molecular Structure | 2017 |
Aminocarboxylic acids related to aspergillomarasmine A (AMA) and ethylenediamine-N,N'-disuccinic acid (EDDS) are strong zinc-binders and inhibitors of the metallo-beta-lactamase NDM-1.
Topics: Amino Acids; Aspartic Acid; beta-Lactamase Inhibitors; beta-Lactamases; Coordination Complexes; Dose-Response Relationship, Drug; Escherichia coli Proteins; Ethylenediamines; Molecular Structure; Structure-Activity Relationship; Succinates; Zinc | 2020 |
Aspergillomarasmine A inhibits metallo-β-lactamases by selectively sequestering Zn
Topics: Anti-Bacterial Agents; Aspartic Acid; Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Chelating Agents; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Zinc | 2021 |